Lanean...
Abatacept experience in steroid and rituximab-resistant focal segmental glomerulosclerosis
Primary focal segmental glomerular sclerosis (FSGS), one of the major causes of nephrotic syndrome, eventually results in end-stage renal disease. Currently, FSGS is treated with immunosuppressive therapies, which include calcinuerin inhibitors (cyclosporine), glucocorticoids, B-cell depleting agent...
Gorde:
| Argitaratua izan da: | BMJ Case Rep |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMJ Publishing Group
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5483571/ https://ncbi.nlm.nih.gov/pubmed/26887886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2016-214396 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|